USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Univerza V Ljubjani

USPTO PatentsView assignee record - 11 granted patents across 20 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS).

The verdict

According to USPTO PatentsView, Univerza ranks #25,477 of 50,000 tracked US assignees by granted-patent volume, with 11 patents across 20 technology areas.

#25,477
of 50,000 US assignees by volume
Top 11%
by Innovation Score (51.8/100)
12.3
avg claims per patent
+200%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R25477 · Foreign Corporation #25,477 · 11 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-MICRO 11 grants
  • MID-PACK #25,477/50,000
  • PHOTO-FINISH University of Denver
  • CPC-FOCUS A61P · 20 areas
  • INNOV-PAR 51.8/100
  • CLAIMS-RICH 12.3 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-SURGE +200% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: University Of Denver (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Univerza

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Univerza's Innovation Score is 51.8/100 (top 11% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Where Univerza's grants concentrate

Univerza V Ljubjani is a focused PatentsView assignee: 20 CPC subclasses with 36.4% of grants classified under A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS). Peak complete grant year is 2022 (2 grants) versus a trough of 1 in 2017. By volume, Univerza sits between University Of Denver and V.v.t. Med Ltd..

Univerza's three-year grant acceleration

Univerza V Ljubjani shows 5 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Univerza's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Univerza holds 11 patents at rank #25,462, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Univerza

By rank, the assignees closest to #25,462 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Univerza's primary technology class.

Univerza's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

52 Top 11% higher than 89% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). Below this entry. 40–50: 11,491 US assignees (23%). Below this entry. 50–60: 5,058 US assignees (10%). This entry sits in this band. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0.511.522.533.5 2017201820212022202320242025 3
USPTO utility patent grants by year · 2017–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table
Univerza V Ljubjani patent grants by year, 2015–2025
Year Patents Granted Share of Period
2017 1 9.1%
2018 1 9.1%
2021 1 9.1%
2022 2 18.2%
2023 1 9.1%
2024 2 18.2%
2025partial year 3 27.3%

Which technologies does Univerza V Ljubjani patent most?

Top 15 of 20 technology areas

Where it ranks

Overall rank by patents

#25,477

of 50,000 tracked assignees

Innovation Score

51.8 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.